tirzepatide and bpc 157 isn't a weight drug. It's an inflammation drug that happens to help with weight. That's why it's quietly changing the MCAS conversation. Dual GLP-1 / GIP agonist. GLP-1 slows gut motility tirzepatide + bpc-157 side effects

Clinical trials with tirzepatide (SURMOUNT-1, SURMOUNT-2, and SURMOUNT-3) demonstrated that participants titrated to higher maintenance doses achieved greater weight loss than those on lower doses

Scientific References #1

In 2023, the high demand and possible off-label of this medication to treat obesity led to supply shortages of Wegovy

Weeks of no visible movement often precede a drop

it's just a signal, and like any signal, it tells you something about the state of your body

Thus, under asthmatic conditions, intracellular GSH levels could reflect not only the generation of reactive hydroperoxy-phospholipids by the 15LO1-PEBP1 complex, but also the compensatory levels and activity of GPX4, the availability of newly synthesized and regenerated GSH, as well as extracellular transport